12-(1-pyrene)dodecanoic acid has been researched along with Peroxisomal Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imanaka, T; Kawaguchi, K; Matsumoto, S; Matsuya, Y; Minato, D; Morita, M; Okazaki, A; Shimozawa, N; Tomita, K; Watanabe, S | 1 |
| Bogaki, A; Fujiki, Y; Okumoto, K; Orii, T; Osumi, T; Shimozawa, N; Suzuki, Y; Tateishi, K; Tsukamoto, T | 1 |
2 other study(ies) available for 12-(1-pyrene)dodecanoic acid and Peroxisomal Disorders
| Article | Year |
|---|---|
A novel method for determining peroxisomal fatty acid β-oxidation.
Topics: Adrenoleukodystrophy; Carnitine Acyltransferases; Cells, Cultured; Fatty Acids; Fibroblasts; Humans; Lauric Acids; Lipid Metabolism, Inborn Errors; Mitochondria; Oxidation-Reduction; Peroxisomal Disorders; Peroxisomes; Pyrenes; Skin; Zellweger Syndrome | 2016 |
Isolation and characterization of peroxisome-deficient Chinese hamster ovary cell mutants representing human complementation group III.
Topics: Adenosine Triphosphatases; Animals; ATPases Associated with Diverse Cellular Activities; CHO Cells; Cricetinae; Drug Resistance; Genetic Complementation Test; Humans; Lauric Acids; Microbodies; Mutation; Peroxisomal Disorders; Zellweger Syndrome | 1997 |